nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—CHRNA5—chronic obstructive pulmonary disease	0.419	0.681	CbGaD
Galantamine—CHRNA3—chronic obstructive pulmonary disease	0.196	0.319	CbGaD
Galantamine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.017	0.17	CbGbCtD
Galantamine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.017	0.17	CbGbCtD
Galantamine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0151	0.152	CbGbCtD
Galantamine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0142	0.143	CbGbCtD
Galantamine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00962	0.0966	CbGbCtD
Galantamine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00917	0.0921	CbGbCtD
Galantamine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00818	0.0821	CbGbCtD
Galantamine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0048	0.0482	CbGbCtD
Galantamine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00453	0.0455	CbGbCtD
Galantamine—BCHE—diaphragm—chronic obstructive pulmonary disease	0.00346	0.198	CbGeAlD
Galantamine—CHRND—respiratory system—chronic obstructive pulmonary disease	0.00144	0.0823	CbGeAlD
Galantamine—CHRNG—trachea—chronic obstructive pulmonary disease	0.00134	0.0767	CbGeAlD
Galantamine—CHRNA3—respiratory system—chronic obstructive pulmonary disease	0.00107	0.0613	CbGeAlD
Galantamine—CHRNG—lung—chronic obstructive pulmonary disease	0.000962	0.0551	CbGeAlD
Galantamine—CHRNB2—bronchus—chronic obstructive pulmonary disease	0.000909	0.052	CbGeAlD
Galantamine—CHRNB2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000889	0.0509	CbGeAlD
Galantamine—CHRFAM7A—respiratory system—chronic obstructive pulmonary disease	0.000866	0.0496	CbGeAlD
Galantamine—CHRNB2—trachea—chronic obstructive pulmonary disease	0.000816	0.0467	CbGeAlD
Galantamine—CHRND—lung—chronic obstructive pulmonary disease	0.000763	0.0437	CbGeAlD
Galantamine—CHRNA4—respiratory system—chronic obstructive pulmonary disease	0.00069	0.0395	CbGeAlD
Galantamine—CHRFAM7A—trachea—chronic obstructive pulmonary disease	0.00064	0.0366	CbGeAlD
Galantamine—CHRNB2—lung—chronic obstructive pulmonary disease	0.000586	0.0336	CbGeAlD
Galantamine—CHRNA3—lung—chronic obstructive pulmonary disease	0.000569	0.0325	CbGeAlD
Galantamine—CHRNA4—bronchus—chronic obstructive pulmonary disease	0.000568	0.0325	CbGeAlD
Galantamine—BCHE—respiratory system—chronic obstructive pulmonary disease	0.000395	0.0226	CbGeAlD
Galantamine—CHRNA4—lung—chronic obstructive pulmonary disease	0.000366	0.021	CbGeAlD
Galantamine—BCHE—bronchus—chronic obstructive pulmonary disease	0.000325	0.0186	CbGeAlD
Galantamine—BCHE—smooth muscle tissue—chronic obstructive pulmonary disease	0.000318	0.0182	CbGeAlD
Galantamine—BCHE—trachea—chronic obstructive pulmonary disease	0.000292	0.0167	CbGeAlD
Galantamine—BCHE—lung—chronic obstructive pulmonary disease	0.00021	0.012	CbGeAlD
Galantamine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.00124	CcSEcCtD
Galantamine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.00124	CcSEcCtD
Galantamine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000151	0.00123	CcSEcCtD
Galantamine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000151	0.00123	CcSEcCtD
Galantamine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000151	0.00123	CcSEcCtD
Galantamine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000151	0.00123	CcSEcCtD
Galantamine—Cough—Montelukast—chronic obstructive pulmonary disease	0.000149	0.00122	CcSEcCtD
Galantamine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.00121	CcSEcCtD
Galantamine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000149	0.00121	CcSEcCtD
Galantamine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000149	0.00121	CcSEcCtD
Galantamine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.00121	CcSEcCtD
Galantamine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.00121	CcSEcCtD
Galantamine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000149	0.00121	CcSEcCtD
Galantamine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.00121	CcSEcCtD
Galantamine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000148	0.00121	CcSEcCtD
Galantamine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.00121	CcSEcCtD
Galantamine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000148	0.00121	CcSEcCtD
Galantamine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.00121	CcSEcCtD
Galantamine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000148	0.00121	CcSEcCtD
Galantamine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000148	0.00121	CcSEcCtD
Galantamine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.00121	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.0012	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000148	0.0012	CcSEcCtD
Galantamine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.0012	CcSEcCtD
Galantamine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000147	0.0012	CcSEcCtD
Galantamine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00119	CcSEcCtD
Galantamine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000146	0.00119	CcSEcCtD
Galantamine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000146	0.00119	CcSEcCtD
Galantamine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000145	0.00119	CcSEcCtD
Galantamine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000145	0.00119	CcSEcCtD
Galantamine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000145	0.00118	CcSEcCtD
Galantamine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.00118	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000145	0.00118	CcSEcCtD
Galantamine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000144	0.00118	CcSEcCtD
Galantamine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.00117	CcSEcCtD
Galantamine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.00116	CcSEcCtD
Galantamine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.00114	CcSEcCtD
Galantamine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.00114	CcSEcCtD
Galantamine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.00114	CcSEcCtD
Galantamine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.00114	CcSEcCtD
Galantamine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.00114	CcSEcCtD
Galantamine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00014	0.00114	CcSEcCtD
Galantamine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00014	0.00114	CcSEcCtD
Galantamine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000139	0.00113	CcSEcCtD
Galantamine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.00113	CcSEcCtD
Galantamine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.00113	CcSEcCtD
Galantamine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000138	0.00113	CcSEcCtD
Galantamine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000138	0.00113	CcSEcCtD
Galantamine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000138	0.00113	CcSEcCtD
Galantamine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000138	0.00112	CcSEcCtD
Galantamine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.00112	CcSEcCtD
Galantamine—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00112	CcSEcCtD
Galantamine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000137	0.00112	CcSEcCtD
Galantamine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000137	0.00111	CcSEcCtD
Galantamine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000136	0.00111	CcSEcCtD
Galantamine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000133	0.00109	CcSEcCtD
Galantamine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000133	0.00109	CcSEcCtD
Galantamine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.00108	CcSEcCtD
Galantamine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.00108	CcSEcCtD
Galantamine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.00107	CcSEcCtD
Galantamine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.00107	CcSEcCtD
Galantamine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00013	0.00106	CcSEcCtD
Galantamine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.00106	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00013	0.00106	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00013	0.00106	CcSEcCtD
Galantamine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000129	0.00105	CcSEcCtD
Galantamine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.00105	CcSEcCtD
Galantamine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.00105	CcSEcCtD
Galantamine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000128	0.00104	CcSEcCtD
Galantamine—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00104	CcSEcCtD
Galantamine—CHRNA6—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000127	0.000873	CbGpPWpGaD
Galantamine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000127	0.00104	CcSEcCtD
Galantamine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000127	0.00103	CcSEcCtD
Galantamine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.00103	CcSEcCtD
Galantamine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000126	0.00103	CcSEcCtD
Galantamine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000126	0.000865	CbGpPWpGaD
Galantamine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.00102	CcSEcCtD
Galantamine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.00102	CcSEcCtD
Galantamine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000125	0.00102	CcSEcCtD
Galantamine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000125	0.00102	CcSEcCtD
Galantamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000125	0.000857	CbGpPWpGaD
Galantamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000125	0.000856	CbGpPWpGaD
Galantamine—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000125	0.000856	CbGpPWpGaD
Galantamine—Injury—Prednisone—chronic obstructive pulmonary disease	0.000124	0.00101	CcSEcCtD
Galantamine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000124	0.00101	CcSEcCtD
Galantamine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000124	0.00101	CcSEcCtD
Galantamine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.001	CcSEcCtD
Galantamine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000123	0.001	CcSEcCtD
Galantamine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000123	0.001	CcSEcCtD
Galantamine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.001	CcSEcCtD
Galantamine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000123	0.001	CcSEcCtD
Galantamine—CHRNE—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000123	0.000842	CbGpPWpGaD
Galantamine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.000999	CcSEcCtD
Galantamine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.000993	CcSEcCtD
Galantamine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000122	0.000993	CcSEcCtD
Galantamine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.000992	CcSEcCtD
Galantamine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.000985	CcSEcCtD
Galantamine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00012	0.000982	CcSEcCtD
Galantamine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00012	0.000981	CcSEcCtD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.00012	0.000821	CbGpPWpGaD
Galantamine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.000975	CcSEcCtD
Galantamine—CHRNB2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000119	0.000818	CbGpPWpGaD
Galantamine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000119	0.00097	CcSEcCtD
Galantamine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.000967	CcSEcCtD
Galantamine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.000966	CcSEcCtD
Galantamine—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000965	CcSEcCtD
Galantamine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000118	0.000962	CcSEcCtD
Galantamine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000118	0.000962	CcSEcCtD
Galantamine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000117	0.000957	CcSEcCtD
Galantamine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000117	0.000957	CcSEcCtD
Galantamine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000117	0.000956	CcSEcCtD
Galantamine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.000954	CcSEcCtD
Galantamine—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000953	CcSEcCtD
Galantamine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000117	0.000952	CcSEcCtD
Galantamine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.00095	CcSEcCtD
Galantamine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000116	0.00095	CcSEcCtD
Galantamine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000949	CcSEcCtD
Galantamine—CHRND—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000116	0.000798	CbGpPWpGaD
Galantamine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.000947	CcSEcCtD
Galantamine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.000946	CcSEcCtD
Galantamine—ACHE—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000116	0.000794	CbGpPWpGaD
Galantamine—CHRNB4—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000115	0.00079	CbGpPWpGaD
Galantamine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.000938	CcSEcCtD
Galantamine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000114	0.00093	CcSEcCtD
Galantamine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000113	0.000918	CcSEcCtD
Galantamine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.000918	CcSEcCtD
Galantamine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.000918	CcSEcCtD
Galantamine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000113	0.000918	CcSEcCtD
Galantamine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000112	0.000915	CcSEcCtD
Galantamine—CHRNB2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000112	0.000768	CbGpPWpGaD
Galantamine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000111	0.000908	CcSEcCtD
Galantamine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000111	0.000907	CcSEcCtD
Galantamine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000111	0.000907	CcSEcCtD
Galantamine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000904	CcSEcCtD
Galantamine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000111	0.000902	CcSEcCtD
Galantamine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000901	CcSEcCtD
Galantamine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000899	CcSEcCtD
Galantamine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000899	CcSEcCtD
Galantamine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000897	CcSEcCtD
Galantamine—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.00089	CcSEcCtD
Galantamine—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000886	CcSEcCtD
Galantamine—ACHE—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000108	0.000744	CbGpPWpGaD
Galantamine—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000108	0.000743	CbGpPWpGaD
Galantamine—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000108	0.000743	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000108	0.000741	CbGpPWpGaD
Galantamine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000107	0.000736	CbGpPWpGaD
Galantamine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000867	CcSEcCtD
Galantamine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000867	CcSEcCtD
Galantamine—CHRNA3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000105	0.000722	CbGpPWpGaD
Galantamine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000105	0.000856	CcSEcCtD
Galantamine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000105	0.000856	CcSEcCtD
Galantamine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000105	0.000855	CcSEcCtD
Galantamine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.000853	CcSEcCtD
Galantamine—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000847	CcSEcCtD
Galantamine—CHRNA6—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000104	0.000712	CbGpPWpGaD
Galantamine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000103	0.000838	CcSEcCtD
Galantamine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000102	0.000833	CcSEcCtD
Galantamine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.000833	CcSEcCtD
Galantamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000102	0.000699	CbGpPWpGaD
Galantamine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000101	0.00082	CcSEcCtD
Galantamine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.0001	0.000816	CcSEcCtD
Galantamine—CHRNA7—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	9.98e-05	0.000685	CbGpPWpGaD
Galantamine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	9.91e-05	0.000808	CcSEcCtD
Galantamine—CHRNA1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	9.88e-05	0.000678	CbGpPWpGaD
Galantamine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	9.84e-05	0.000676	CbGpPWpGaD
Galantamine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	9.75e-05	0.000795	CcSEcCtD
Galantamine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	9.75e-05	0.000795	CcSEcCtD
Galantamine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	9.7e-05	0.000791	CcSEcCtD
Galantamine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	9.65e-05	0.000787	CcSEcCtD
Galantamine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	9.55e-05	0.000656	CbGpPWpGaD
Galantamine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	9.55e-05	0.000779	CcSEcCtD
Galantamine—ACHE—ATF-2 transcription factor network—TGFB2—chronic obstructive pulmonary disease	9.52e-05	0.000654	CbGpPWpGaD
Galantamine—CHRND—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	9.47e-05	0.00065	CbGpPWpGaD
Galantamine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	9.42e-05	0.000768	CcSEcCtD
Galantamine—Dizziness—Formoterol—chronic obstructive pulmonary disease	9.42e-05	0.000768	CcSEcCtD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	9.42e-05	0.000647	CbGpPWpGaD
Galantamine—CHRNA2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	9.39e-05	0.000644	CbGpPWpGaD
Galantamine—CHRNB4—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	9.38e-05	0.000644	CbGpPWpGaD
Galantamine—Dizziness—Montelukast—chronic obstructive pulmonary disease	9.23e-05	0.000752	CcSEcCtD
Galantamine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	9.2e-05	0.000751	CcSEcCtD
Galantamine—CHRNB2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	9.12e-05	0.000626	CbGpPWpGaD
Galantamine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	9.06e-05	0.000739	CcSEcCtD
Galantamine—Vomiting—Formoterol—chronic obstructive pulmonary disease	9.06e-05	0.000739	CcSEcCtD
Galantamine—Rash—Formoterol—chronic obstructive pulmonary disease	8.98e-05	0.000732	CcSEcCtD
Galantamine—Rash—Arformoterol—chronic obstructive pulmonary disease	8.98e-05	0.000732	CcSEcCtD
Galantamine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	8.97e-05	0.000732	CcSEcCtD
Galantamine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	8.97e-05	0.000732	CcSEcCtD
Galantamine—Headache—Arformoterol—chronic obstructive pulmonary disease	8.92e-05	0.000728	CcSEcCtD
Galantamine—Headache—Formoterol—chronic obstructive pulmonary disease	8.92e-05	0.000728	CcSEcCtD
Galantamine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	8.92e-05	0.000727	CcSEcCtD
Galantamine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	8.91e-05	0.000726	CcSEcCtD
Galantamine—CHRND—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	8.9e-05	0.000611	CbGpPWpGaD
Galantamine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	8.89e-05	0.000725	CcSEcCtD
Galantamine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	8.89e-05	0.000725	CcSEcCtD
Galantamine—Vomiting—Montelukast—chronic obstructive pulmonary disease	8.87e-05	0.000723	CcSEcCtD
Galantamine—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	8.82e-05	0.000606	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	8.82e-05	0.000605	CbGpPWpGaD
Galantamine—CHRNB4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	8.81e-05	0.000605	CbGpPWpGaD
Galantamine—Rash—Montelukast—chronic obstructive pulmonary disease	8.8e-05	0.000717	CcSEcCtD
Galantamine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	8.79e-05	0.000717	CcSEcCtD
Galantamine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	8.77e-05	0.000715	CcSEcCtD
Galantamine—Depression—Prednisone—chronic obstructive pulmonary disease	8.76e-05	0.000715	CcSEcCtD
Galantamine—Headache—Montelukast—chronic obstructive pulmonary disease	8.74e-05	0.000713	CcSEcCtD
Galantamine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	8.62e-05	0.000703	CcSEcCtD
Galantamine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	8.55e-05	0.000697	CcSEcCtD
Galantamine—Malaise—Prednisolone—chronic obstructive pulmonary disease	8.52e-05	0.000695	CcSEcCtD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	8.5e-05	0.000584	CbGpPWpGaD
Galantamine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	8.49e-05	0.000693	CcSEcCtD
Galantamine—Rash—Salbutamol—chronic obstructive pulmonary disease	8.48e-05	0.000692	CcSEcCtD
Galantamine—Syncope—Prednisolone—chronic obstructive pulmonary disease	8.48e-05	0.000691	CcSEcCtD
Galantamine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	8.47e-05	0.000691	CcSEcCtD
Galantamine—Nausea—Arformoterol—chronic obstructive pulmonary disease	8.46e-05	0.00069	CcSEcCtD
Galantamine—Nausea—Formoterol—chronic obstructive pulmonary disease	8.46e-05	0.00069	CcSEcCtD
Galantamine—Headache—Salbutamol—chronic obstructive pulmonary disease	8.43e-05	0.000687	CcSEcCtD
Galantamine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	8.31e-05	0.000678	CcSEcCtD
Galantamine—Nausea—Montelukast—chronic obstructive pulmonary disease	8.29e-05	0.000676	CcSEcCtD
Galantamine—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	8.23e-05	0.000565	CbGpPWpGaD
Galantamine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	8.19e-05	0.000668	CcSEcCtD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	8.18e-05	0.000561	CbGpPWpGaD
Galantamine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	8.16e-05	0.000666	CcSEcCtD
Galantamine—CHRNA4—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	8.14e-05	0.000559	CbGpPWpGaD
Galantamine—CHRNA7—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	8.14e-05	0.000559	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	8.09e-05	0.000556	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	8.06e-05	0.000554	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	8.06e-05	0.000553	CbGpPWpGaD
Galantamine—CHRNA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	8.05e-05	0.000553	CbGpPWpGaD
Galantamine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	8.03e-05	0.000655	CcSEcCtD
Galantamine—Nausea—Salbutamol—chronic obstructive pulmonary disease	7.99e-05	0.000652	CcSEcCtD
Galantamine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	7.95e-05	0.000648	CcSEcCtD
Galantamine—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	7.93e-05	0.000647	CcSEcCtD
Galantamine—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	7.92e-05	0.000544	CbGpPWpGaD
Galantamine—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	7.89e-05	0.000643	CcSEcCtD
Galantamine—Hallucination—Prednisone—chronic obstructive pulmonary disease	7.85e-05	0.00064	CcSEcCtD
Galantamine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	7.75e-05	0.000632	CcSEcCtD
Galantamine—CHRNA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	7.65e-05	0.000525	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	7.65e-05	0.000525	CbGpPWpGaD
Galantamine—Shock—Prednisolone—chronic obstructive pulmonary disease	7.59e-05	0.000619	CcSEcCtD
Galantamine—CHRNA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	7.57e-05	0.00052	CbGpPWpGaD
Galantamine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	7.53e-05	0.000614	CcSEcCtD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	7.48e-05	0.000514	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	7.47e-05	0.000513	CbGpPWpGaD
Galantamine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	7.46e-05	0.000608	CcSEcCtD
Galantamine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	7.41e-05	0.000509	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	7.38e-05	0.000507	CbGpPWpGaD
Galantamine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	7.37e-05	0.000601	CcSEcCtD
Galantamine—Flushing—Prednisone—chronic obstructive pulmonary disease	7.32e-05	0.000597	CcSEcCtD
Galantamine—CHRND—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	7.26e-05	0.000498	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	7.19e-05	0.000494	CbGpPWpGaD
Galantamine—CHRNB4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	7.18e-05	0.000493	CbGpPWpGaD
Galantamine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	7.16e-05	0.000584	CcSEcCtD
Galantamine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	7.15e-05	0.000491	CbGpPWpGaD
Galantamine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	7.13e-05	0.000581	CcSEcCtD
Galantamine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	7.05e-05	0.000575	CcSEcCtD
Galantamine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	6.98e-05	0.000569	CcSEcCtD
Galantamine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	6.93e-05	0.000565	CcSEcCtD
Galantamine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	6.91e-05	0.000564	CcSEcCtD
Galantamine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	6.87e-05	0.00056	CcSEcCtD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	6.66e-05	0.000458	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	6.63e-05	0.000455	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	6.62e-05	0.000455	CbGpPWpGaD
Galantamine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	6.47e-05	0.000528	CcSEcCtD
Galantamine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	6.43e-05	0.000442	CbGpPWpGaD
Galantamine—ACHE—Peptide hormone metabolism—ACE—chronic obstructive pulmonary disease	6.4e-05	0.00044	CbGpPWpGaD
Galantamine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	6.37e-05	0.00052	CcSEcCtD
Galantamine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	6.36e-05	0.000518	CcSEcCtD
Galantamine—Anaemia—Prednisone—chronic obstructive pulmonary disease	6.35e-05	0.000518	CcSEcCtD
Galantamine—Agitation—Prednisone—chronic obstructive pulmonary disease	6.31e-05	0.000515	CcSEcCtD
Galantamine—CHRNA4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	6.24e-05	0.000428	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	6.24e-05	0.000428	CbGpPWpGaD
Galantamine—Malaise—Prednisone—chronic obstructive pulmonary disease	6.19e-05	0.000505	CcSEcCtD
Galantamine—Vertigo—Prednisone—chronic obstructive pulmonary disease	6.17e-05	0.000503	CcSEcCtD
Galantamine—CHRNA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	6.17e-05	0.000424	CbGpPWpGaD
Galantamine—Syncope—Prednisone—chronic obstructive pulmonary disease	6.16e-05	0.000502	CcSEcCtD
Galantamine—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	6.12e-05	0.00042	CbGpPWpGaD
Galantamine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	6.04e-05	0.000492	CcSEcCtD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	6.01e-05	0.000413	CbGpPWpGaD
Galantamine—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	5.98e-05	0.000411	CbGpPWpGaD
Galantamine—Convulsion—Prednisone—chronic obstructive pulmonary disease	5.95e-05	0.000485	CcSEcCtD
Galantamine—Hypertension—Prednisone—chronic obstructive pulmonary disease	5.93e-05	0.000484	CcSEcCtD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	5.89e-05	0.000405	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	5.86e-05	0.000402	CbGpPWpGaD
Galantamine—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	5.86e-05	0.000402	CbGpPWpGaD
Galantamine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	5.85e-05	0.000477	CcSEcCtD
Galantamine—Myalgia—Prednisone—chronic obstructive pulmonary disease	5.85e-05	0.000477	CcSEcCtD
Galantamine—Anxiety—Prednisone—chronic obstructive pulmonary disease	5.83e-05	0.000475	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	5.81e-05	0.000474	CcSEcCtD
Galantamine—ACHE—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	5.81e-05	0.000399	CbGpPWpGaD
Galantamine—Discomfort—Prednisone—chronic obstructive pulmonary disease	5.78e-05	0.000471	CcSEcCtD
Galantamine—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	5.75e-05	0.000395	CbGpPWpGaD
Galantamine—BCHE—Peptide hormone metabolism—ACE—chronic obstructive pulmonary disease	5.71e-05	0.000392	CbGpPWpGaD
Galantamine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	5.68e-05	0.000464	CcSEcCtD
Galantamine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	5.61e-05	0.000385	CbGpPWpGaD
Galantamine—ACHE—Monoamine Transport—IL1B—chronic obstructive pulmonary disease	5.54e-05	0.00038	CbGpPWpGaD
Galantamine—Shock—Prednisone—chronic obstructive pulmonary disease	5.52e-05	0.00045	CcSEcCtD
Galantamine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	5.5e-05	0.000448	CcSEcCtD
Galantamine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	5.47e-05	0.000446	CcSEcCtD
Galantamine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	5.44e-05	0.000444	CcSEcCtD
Galantamine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	5.42e-05	0.000442	CcSEcCtD
Galantamine—ACHE—ATF-2 transcription factor network—PLAU—chronic obstructive pulmonary disease	5.4e-05	0.000371	CbGpPWpGaD
Galantamine—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	5.38e-05	0.00037	CbGpPWpGaD
Galantamine—Anorexia—Prednisone—chronic obstructive pulmonary disease	5.34e-05	0.000436	CcSEcCtD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	5.21e-05	0.000358	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	5.18e-05	0.000356	CbGpPWpGaD
Galantamine—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	5.18e-05	0.000355	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	5.11e-05	0.000351	CbGpPWpGaD
Galantamine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	5.11e-05	0.000417	CcSEcCtD
Galantamine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5.1e-05	0.000416	CcSEcCtD
Galantamine—CHRNA4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	5.08e-05	0.000349	CbGpPWpGaD
Galantamine—Insomnia—Prednisone—chronic obstructive pulmonary disease	5.07e-05	0.000413	CcSEcCtD
Galantamine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	5.03e-05	0.000411	CcSEcCtD
Galantamine—CHRNB2—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	5.03e-05	0.000345	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—NOS2—chronic obstructive pulmonary disease	4.96e-05	0.000341	CbGpPWpGaD
Galantamine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	4.93e-05	0.000402	CcSEcCtD
Galantamine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	4.87e-05	0.000397	CcSEcCtD
Galantamine—Rash—Prednisolone—chronic obstructive pulmonary disease	4.86e-05	0.000397	CcSEcCtD
Galantamine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	4.86e-05	0.000396	CcSEcCtD
Galantamine—Fatigue—Prednisone—chronic obstructive pulmonary disease	4.83e-05	0.000394	CcSEcCtD
Galantamine—Headache—Prednisolone—chronic obstructive pulmonary disease	4.83e-05	0.000394	CcSEcCtD
Galantamine—Constipation—Prednisone—chronic obstructive pulmonary disease	4.79e-05	0.000391	CcSEcCtD
Galantamine—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	4.74e-05	0.000326	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	4.73e-05	0.000325	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	4.69e-05	0.000322	CbGpPWpGaD
Galantamine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	4.68e-05	0.000321	CbGpPWpGaD
Galantamine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	4.62e-05	0.000377	CcSEcCtD
Galantamine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	4.58e-05	0.000374	CcSEcCtD
Galantamine—Nausea—Prednisolone—chronic obstructive pulmonary disease	4.58e-05	0.000374	CcSEcCtD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	4.53e-05	0.000311	CbGpPWpGaD
Galantamine—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	4.49e-05	0.000308	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	4.45e-05	0.000305	CbGpPWpGaD
Galantamine—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	4.44e-05	0.000305	CbGpPWpGaD
Galantamine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	4.43e-05	0.000361	CcSEcCtD
Galantamine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	4.43e-05	0.000361	CcSEcCtD
Galantamine—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	4.25e-05	0.000292	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	4.22e-05	0.00029	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	4.17e-05	0.000286	CbGpPWpGaD
Galantamine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.13e-05	0.000337	CcSEcCtD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	4.09e-05	0.000281	CbGpPWpGaD
Galantamine—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.02e-05	0.000328	CcSEcCtD
Galantamine—ACHE—Monoamine Transport—TNF—chronic obstructive pulmonary disease	4.02e-05	0.000276	CbGpPWpGaD
Galantamine—ACHE—Peptide hormone metabolism—LEP—chronic obstructive pulmonary disease	3.98e-05	0.000273	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	3.97e-05	0.000272	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	3.95e-05	0.000271	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	3.93e-05	0.00027	CbGpPWpGaD
Galantamine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	3.91e-05	0.000268	CbGpPWpGaD
Galantamine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	3.84e-05	0.000313	CcSEcCtD
Galantamine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	3.76e-05	0.000258	CbGpPWpGaD
Galantamine—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.71e-05	0.000302	CcSEcCtD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	3.69e-05	0.000253	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	3.63e-05	0.000249	CbGpPWpGaD
Galantamine—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.56e-05	0.000291	CcSEcCtD
Galantamine—BCHE—Peptide hormone metabolism—LEP—chronic obstructive pulmonary disease	3.55e-05	0.000244	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—CXCL8—chronic obstructive pulmonary disease	3.54e-05	0.000243	CbGpPWpGaD
Galantamine—Rash—Prednisone—chronic obstructive pulmonary disease	3.53e-05	0.000288	CcSEcCtD
Galantamine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.53e-05	0.000288	CcSEcCtD
Galantamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	3.52e-05	0.000242	CbGpPWpGaD
Galantamine—Headache—Prednisone—chronic obstructive pulmonary disease	3.51e-05	0.000286	CcSEcCtD
Galantamine—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	3.5e-05	0.00024	CbGpPWpGaD
Galantamine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	3.42e-05	0.000235	CbGpPWpGaD
Galantamine—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	3.37e-05	0.000232	CbGpPWpGaD
Galantamine—Nausea—Prednisone—chronic obstructive pulmonary disease	3.33e-05	0.000272	CcSEcCtD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3.32e-05	0.000228	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	3.23e-05	0.000222	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	3.22e-05	0.000221	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	3.09e-05	0.000212	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	3.08e-05	0.000212	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.04e-05	0.000208	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	2.85e-05	0.000196	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	2.8e-05	0.000192	CbGpPWpGaD
Galantamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	2.77e-05	0.00019	CbGpPWpGaD
Galantamine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	2.76e-05	0.00019	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	2.75e-05	0.000189	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.71e-05	0.000186	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	2.68e-05	0.000184	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	2.62e-05	0.00018	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	2.62e-05	0.00018	CbGpPWpGaD
Galantamine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	2.48e-05	0.000171	CbGpPWpGaD
Galantamine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	2.45e-05	0.000168	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	2.34e-05	0.000161	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.3e-05	0.000158	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	2.29e-05	0.000157	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	2.28e-05	0.000156	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	2.27e-05	0.000156	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	2.24e-05	0.000154	CbGpPWpGaD
Galantamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	2.23e-05	0.000153	CbGpPWpGaD
Galantamine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	2.21e-05	0.000151	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	2.19e-05	0.00015	CbGpPWpGaD
Galantamine—ACHE—Metabolism—APIP—chronic obstructive pulmonary disease	2.1e-05	0.000144	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	2.05e-05	0.000141	CbGpPWpGaD
Galantamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	2.01e-05	0.000138	CbGpPWpGaD
Galantamine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	2.01e-05	0.000138	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—IL6—chronic obstructive pulmonary disease	1.99e-05	0.000137	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	1.95e-05	0.000134	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	1.88e-05	0.000129	CbGpPWpGaD
Galantamine—BCHE—Metabolism—APIP—chronic obstructive pulmonary disease	1.87e-05	0.000128	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	1.85e-05	0.000127	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	1.81e-05	0.000124	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.81e-05	0.000124	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	1.77e-05	0.000122	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	1.75e-05	0.00012	CbGpPWpGaD
Galantamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	1.62e-05	0.000111	CbGpPWpGaD
Galantamine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	1.6e-05	0.00011	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	1.59e-05	0.000109	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.57e-05	0.000108	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.5e-05	0.000103	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	1.47e-05	0.000101	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	1.45e-05	9.97e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.39e-05	9.54e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.38e-05	9.46e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GC—chronic obstructive pulmonary disease	1.35e-05	9.28e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.33e-05	9.16e-05	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	1.32e-05	9.04e-05	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.28e-05	8.79e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.26e-05	8.63e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.24e-05	8.51e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.23e-05	8.44e-05	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.23e-05	8.43e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.21e-05	8.31e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	1.21e-05	8.3e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GC—chronic obstructive pulmonary disease	1.21e-05	8.28e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	1.16e-05	7.95e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	1.14e-05	7.86e-05	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.13e-05	7.75e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.12e-05	7.71e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.12e-05	7.7e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.11e-05	7.64e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	1.09e-05	7.46e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	1.08e-05	7.4e-05	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.07e-05	7.34e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.05e-05	7.24e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.03e-05	7.08e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.01e-05	6.94e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1e-05	6.87e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	9.69e-06	6.65e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	9.63e-06	6.61e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.62e-06	6.61e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.49e-06	6.52e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.93e-06	6.13e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	8.6e-06	5.91e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	8.49e-06	5.83e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.03e-06	5.51e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.92e-06	5.44e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	7.76e-06	5.33e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	7.51e-06	5.16e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.39e-06	5.07e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.38e-06	5.06e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GCLC—chronic obstructive pulmonary disease	7.3e-06	5.01e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.28e-06	4.99e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.99e-06	4.8e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	6.92e-06	4.75e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.9e-06	4.74e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.81e-06	4.67e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	6.7e-06	4.6e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CTGF—chronic obstructive pulmonary disease	6.66e-06	4.57e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.59e-06	4.52e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GCLC—chronic obstructive pulmonary disease	6.51e-06	4.47e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.14e-06	4.21e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.07e-06	4.17e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CTGF—chronic obstructive pulmonary disease	5.94e-06	4.08e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.7e-06	3.91e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	5.63e-06	3.86e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	5.54e-06	3.81e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.48e-06	3.76e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.15e-06	3.54e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.12e-06	3.51e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.05e-06	3.47e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	4.99e-06	3.43e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.7e-06	3.23e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.57e-06	3.14e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.5e-06	3.09e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.46e-06	3.06e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	4.45e-06	3.06e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.2e-06	2.88e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.98e-06	2.73e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.73e-06	2.56e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	3.63e-06	2.49e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.37e-06	2.31e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALB—chronic obstructive pulmonary disease	3.03e-06	2.08e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.03e-06	2.08e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.99e-06	2.06e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NOS3—chronic obstructive pulmonary disease	2.9e-06	1.99e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.73e-06	1.88e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALB—chronic obstructive pulmonary disease	2.7e-06	1.86e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NOS3—chronic obstructive pulmonary disease	2.59e-06	1.78e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.52e-06	1.73e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.1e-06	1.44e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.07e-06	1.42e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.98e-06	1.36e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.96e-06	1.34e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.93e-06	1.32e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.83e-06	1.26e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.79e-06	1.23e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.65e-06	1.13e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.37e-06	9.42e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.35e-06	9.29e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.26e-06	8.66e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	1.24e-06	8.54e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.2e-06	8.21e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.19e-06	8.17e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	8.13e-07	5.58e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	7.78e-07	5.34e-06	CbGpPWpGaD
